Bristol-Myers Squibb Co
BMY
Company Profile
Business description
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Contact
Route 206 and Province Line Road
Princeton
New Jersey NJ 08543
USAT: +1 609 252-4621
E: timothy.power@bms.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
34,100
Bristol-Myers Squibb Co News & Analysis
stocks
The 10 best global companies to invest in now
These undervalued stocks of high-quality companies are attractive investments today.
stocks
3 cheap Wide Moat stocks in a divided industry
All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far.
stocks
3 wide moat shares at five-star prices
Our analysts think these companies enjoy durable competitive advantages with the potential to last for at least 20 years. The shares also look cheap.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,250.70 | 11.70 | -0.14% |
CAC 40 | 7,632.71 | 91.61 | -1.19% |
DAX 40 | 18,590.89 | 157.29 | -0.84% |
Dow JONES (US) | 40,211.72 | 210.82 | 0.53% |
FTSE 100 | 8,182.96 | 69.95 | -0.85% |
HKSE | 17,795.71 | 220.23 | -1.22% |
NASDAQ | 18,472.57 | 74.12 | 0.40% |
Nikkei 225 | 41,399.72 | 209.04 | 0.51% |
NZX 50 Index | 12,118.17 | 4.97 | -0.04% |
S&P 500 | 5,631.22 | 15.87 | 0.28% |
S&P/ASX 200 | 8,004.60 | 13.00 | -0.16% |
SSE Composite Index | 2,966.60 | 7.41 | -0.25% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Droneshield Ltd DRO | 1.93 | 0.67 | -25.77% |
Bellevue Gold Ltd BGL | 1.86 | 0.07 | -3.76% |
Red 5 Ltd RED | 0.42 | 0.00 | 0.60% |
Latin Resources Ltd LRS | 0.16 | 0.01 | -7.35% |
Zip Co Ltd ZIP | 1.60 | 0.03 | 1.59% |
Core Lithium Ltd CXO | 0.11 | 0.01 | -8.33% |
Australian Vanadium Ltd AVL | 0.02 | 0.00 | 3.13% |
Tabcorp Holdings Ltd TAH | 0.69 | 0.01 | -1.44% |
Liontown Resources Ltd LTR | 0.95 | 0.02 | -2.32% |
Mirvac Group MGR | 2.10 | 0.02 | 0.96% |